Not all people with CLL need therapy. Even with all recent innovations, the iwCLL nonetheless suggests watchful observation for sufferers with asymptomatic illness.86 This advice is based on at least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 The two trials concluded that https://brucek315csh2.bloggazza.com/profile